Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Laparoscopic Sleeve Gastrectomy Significantly Increases Serum Lipoprotein Lipase Level in Obese Patients.

Ohira M, Yamaguchi T, Saiki A, Nakamura S, Tanaka S, Oka R, Watanabe Y, Sato Y, Oshiro T, Murano T, Tatsuno I.

Obes Facts. 2019;12(3):357-368. doi: 10.1159/000500360. Epub 2019 Jun 5.

2.

Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.

Saiki A, Oyama T, Endo K, Ebisuno M, Ohira M, Koide N, Murano T, Miyashita Y, Shirai K.

Diabetes Res Clin Pract. 2007 Apr;76(1):93-101. Epub 2006 Sep 7.

PMID:
16956692
3.

Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.

Hitsumoto T, Takahashi M, Iizuka T, Shirai K.

J Cardiol. 2006 Aug;48(2):65-73.

PMID:
16948449
4.

Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy.

Miyashita Y, Shirai K, Itoh Y, Sasaki H, Totsuka M, Murano T, Watanabe H.

Diabetes Res Clin Pract. 2002 Jun;56(3):181-7.

PMID:
11947965
5.

Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia.

Endo K, Miyashita Y, Saiki A, Oyama T, Koide N, Ozaki H, Otsuka M, Ito Y, Shirai K.

J Atheroscler Thromb. 2004;11(6):341-7.

6.

Gender difference in the relationship between serum uric acid reduction and improvement in body fat distribution after laparoscopic sleeve gastrectomy in Chinese obese patients: a 6-month follow-up.

Zhang X, Zhu C, Gao J, Mei F, Yin J, Bu L, Cheng X, Sheng C, Qu S.

Lipids Health Dis. 2018 Dec 20;17(1):288. doi: 10.1186/s12944-018-0934-y.

7.

Effect of the angiotensin II receptor antagonist telmisartan on lipoprotein lipase mass in preheparin serum.

Hitsumoto T, Takahashi M, Iizuka T, Shirai K.

J Atheroscler Thromb. 2008 Jun;15(3):138-45.

8.

Surgery for weight loss in adults.

Colquitt JL, Pickett K, Loveman E, Frampton GK.

Cochrane Database Syst Rev. 2014 Aug 8;(8):CD003641. doi: 10.1002/14651858.CD003641.pub4. Review.

PMID:
25105982
9.

The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.

Saiki A, Ohira M, Endo K, Koide N, Oyama T, Murano T, Miyashita Y, Shirai K.

Diabetes Res Clin Pract. 2006 Dec;74(3):242-8. Epub 2006 May 19.

PMID:
16713009
10.

Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year.

Nocca D, Guillaume F, Noel P, Picot MC, Aggarwal R, El Kamel M, Schaub R, de Seguin de Hons C, Renard E, Fabre JM.

Obes Surg. 2011 Jun;21(6):738-43. doi: 10.1007/s11695-011-0385-2.

PMID:
21468625
11.

Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias.

Watanabe H, Miyashita Y, Murano T, Hiroh Y, Itoh Y, Shirai K.

Atherosclerosis. 1999 Jul;145(1):45-50.

PMID:
10428294
12.

Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients.

Ohira M, Miyashita Y, Ebisuno M, Saiki A, Endo K, Koide N, Oyama T, Murano T, Watanabe H, Shirai K.

Diabetes Res Clin Pract. 2007 Oct;78(1):34-41. Epub 2007 Mar 19.

PMID:
17374417
13.

Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration.

Totsuka M, Miyashita Y, Ito Y, Watanabe H, Murano T, Shirai K.

Atherosclerosis. 2000 Nov;153(1):175-9.

PMID:
11058713
14.

Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis.

Hitsumoto T, Ohsawa H, Uchi T, Noike H, Kanai M, Yoshinuma M, Miyashita Y, Watanabe H, Shirai K.

Atherosclerosis. 2000 Dec;153(2):391-6.

PMID:
11164428
15.

Bioelectrical Impedance Analysis Results for Estimating Body Composition Are Associated with Glucose Metabolism Following Laparoscopic Sleeve Gastrectomy in Obese Japanese Patients.

Ozeki Y, Masaki T, Yoshida Y, Okamoto M, Anai M, Gotoh K, Endo Y, Ohta M, Inomata M, Shibata H.

Nutrients. 2018 Oct 8;10(10). pii: E1456. doi: 10.3390/nu10101456.

16.

Clinical determination of the severity of metabolic syndrome: preheparin lipoprotein lipase mass as a new marker of metabolic syndrome.

Miyashita Y, Shirai K.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Oct;3(4):377-81. Review.

PMID:
16250868
17.

[Effect of laparoscopic sleeve gastrectomy on sex hormone in male severe obesity].

Zhu C, Zhang Y, Wang X, Gao J, Lu L, Zhou D, Qu S.

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Apr 25;20(4):405-410. Chinese.

PMID:
28440521
18.

[Effects of laparoscopic sleeve gastrectomy on insulin secretion patterns in morbidly obese patients].

Qian C, Zhu C, Gao J, Bu L, Zhou D, Li N, Qu S.

Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Jan 25;21(1):61-67. Chinese.

PMID:
29354901
19.

Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking.

Onat A, Hergen├ž G, Agirba┼čli M, Kaya Z, Can G, Unaltuna NE.

Clin Chem Lab Med. 2009;47(2):208-15. doi: 10.1515/CCLM.2009.018.

PMID:
19191728

Supplemental Content

Support Center